ArticleFrontiers in immunology2025

A pilot study of the immunological profile and efficacy of rituximab in muscle-specific kinase antibody-positive myasthenia gravis.

Fengzhan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.